The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes
Open accessAbstract
BACKGROUND: Cryptococcal meningitis (CM) is a leading cause of death in individuals infected with human immunodeficiency virus (HIV). Identifying factors associated with mortality informs strategies to improve outcomes. METHODS: Five hundred one patients with HIV-associated CM were followed prospectively for 10 weeks during trials in Thailand, Uganda, Malawi, and South Africa. South African patients (n = 266) were followed for 1 year. Similar inclusion/exclusion criteria were applied at all sites. Logistic regression identified baseline variables independently associated with mortality. RESULTS: Mortality was 17% at 2 weeks and 34% at 10 weeks. Altered mental status (odds ratio [OR], 3.1; 95% confidence interval [CI], 1.7-5.9), high cerebrospinal fluid (CSF) fungal burden (OR, 1.4 per log10 colony-forming units/mL increase; 95% CI, 1.0-1.8), older age (>50 years; OR, 3.9; 95% CI, 1.4-11.1), high peripheral white blood cell count (>10 × 10(9) cells/L; OR, 8.7; 95% CI, 2.5-30.2), fluconazole-based induction treatment, and slow clearance of CSF infection were independently associated with 2-week mortality. Low body weight, anemia (hemoglobin <7.5 g/dL), and low CSF opening pressure were independently associated with mortality at 10 weeks in addition to altered mental status, high fungal burden, high peripheral white cell count, and older age. In those followed for 1 year, overall mortality was 41%. Immune reconstitution inflammatory syndrome occurred in 13% of patients and was associated with 2-week CSF fungal burden (P = .007), but not with time to initiation of antiretroviral therapy (ART). CONCLUSIONS: CSF fungal burden, altered mental status, and rate of clearance of infection predict acute mortality in HIV-associated CM. The results suggest that earlier diagnosis, more rapidly fungicidal amphotericin-based regimens, and prompt immune reconstitution with ART are priorities for improving outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A strong IFNγ response is indicative of a good prognosis in patients with cryptococcosis123,124.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Self-citationPark, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N. P., Pappas, P. G., & Chiller, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e328322ffac · Cited by 2,062
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
Brouwer, A. E., Rajanuwong, A., Chierakul, W., Griffin, G. E., Larsen, R. A., White, N. J., & Harrison, T. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16301-0 · Cited by 466
Self-citationJarvis, J. N., Lawn, S. D., Vogt, M., Bangani, N., Wood, R., & Harrison, T. S. (2009) · Clinical Infectious Diseases · doi:10.1086/597262 · Cited by 315
Self-citationKambugu, A., Meya, D. B., Rhein, J., O’Brien, M. P., Janoff, E. N., Ronald, A., Kamya, M. R., Mayanja‐Kizza, H., Sande, M. A., Bohjanen, P. R., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587667 · Cited by 299
Jarvis, J. N., Percival, A. L., Bauman, S. K., Pelfrey, J. M., Meintjes, G., Williams, G. N., Longley, N., Harrison, T. S., & Kozel, T. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir613 · Cited by 295
Self-citationMeya, D. B., Manabe, Y. C., Castelnuovo, B., Cook, B. A., Elbireer, A., Kambugu, A. D., Kamya, M. R., Bohjanen, P. R., & Boulware, D. R. (2010) · Clinical Infectious Diseases · doi:10.1086/655143 · Cited by 294
Jarvis, J. N., Meintjes, G., Rebe, K., Williams, G. N., Bicanic, T., Williams, A., Schutz, C., Bekker, L.-G., Wood, R., & Harrison, T. S. (2012) · AIDS · doi:10.1097/qad.0b013e3283536a93 · Cited by 290
Self-citationCorticosteroids for Bacterial Meningitis in Adults in Sub-Saharan Africa
Scarborough, M., Gordon, S. B., Whitty, C. W. M., French, N., Njalale, Y., Chitani, A., Peto, T., Lalloo, D. G., & Zijlstra, E. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065711 · Cited by 278
Bicanic, T. A., Meintjes, G., Wood, R., Hayes, M., Rebe, K. B., Bekker, L., & Harrison, T. S. (2007) · Clinical Infectious Diseases · doi:10.1086/518607 · Cited by 271
Self-citation
Cited by
Sorted by citations
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861
Self-citationMaziarz, E. K., & Perfect, J. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.006 · Cited by 698
Limper, A. H., Adenis, A., Le, T., & Harrison, T. S. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30303-1 · Cited by 472
Self-citationCryptococcal meningitis: epidemiology, immunology, diagnosis and therapy
Williamson, P. R., Jarvis, J. N., Panackal, A. A., Fisher, M. C., Molloy, S. F., Loyse, A., & Harrison, T. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.167 · Cited by 487
Self-citationAntifungal Combinations for Treatment of Cryptococcal Meningitis in Africa
Molloy, S. F., Kanyama, C., Heyderman, R. S., Loyse, A., Kouanfack, C., Chanda, D. M., Mfinanga, S., Temfack, E., Lakhi, S., Kivuyo, S. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710922 · Cited by 397
Self-citation
Metadata
- Authors
- Jarvis, J. N., Bicanic, T., Loyse, A., Namarika, D., Jackson, A., Nussbaum, J. C., Longley, N., Muzoora, C., Phulusa, J., Taseera, K., Kanyembe, C., Wilson, D., Hosseinipour, M. C., Brouwer, A. E., Limmathurotsakul, D., White, N., van der Horst, C., Wood, R., Meintjes, G., Bradley, J., Jaffar, S., & Harrison, T.
- Affiliations
- University of Cape Town (ZA)
- St George's, University of London (GB)
- University of California, San Francisco (US)
- Mbarara University of Science and Technology (UG)
- Edendale Hospital (ZA)
- Radboud University Medical Center (NL)
- Mahidol University (TH)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Jarvis, Joseph N.
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-12-06
- Volume
- 58
- Issue
- 5
- Pages
- 736-745
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC3922213
- OpenAlex
- W2101195119
- Cited by
- 367
- References
- 30
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 30 · 2023: 22 · 2022: 24 · 2021: 28 · 2020: 31 · 2019: 39 · 2018: 39 · 2017: 37 · 2016: 28 · 2015: 29 · 2014: 19
- FWCI
- 18.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Greater South Information System
- Funders
- Wellcome Trust (84323)
- National Institute for Health and Care Research (CL-2012-20-001)
- Medical Research Council (MR/K012126/1)
- National Institute of Allergy and Infectious Diseases (P30AI045008, P30AI050410)
- Fogarty International Center (D43TW001039)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- cryptococcal meningitis, HIV, mortality determinants, altered mental status, immune reconstitution inflammatory syndrome, amphotericin B, fluconazole, antiretroviral therapy, anemia, CSF opening pressure, age, white blood cell count
- MeSH terms
- Adult, Africa, Mental Disorders, Cerebrospinal Fluid, Female, Humans, Longitudinal Studies, Male, Prospective Studies, Risk Factors, Thailand, Colony Count, Microbial, Cohort Studies, HIV Infections, Meningitis, Cryptococcal, AIDS-Related Opportunistic Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review